pubmed-article:10755535 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10755535 | lifeskim:mentions | umls-concept:C0206193 | lld:lifeskim |
pubmed-article:10755535 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:10755535 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
pubmed-article:10755535 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
pubmed-article:10755535 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
pubmed-article:10755535 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:10755535 | pubmed:dateCreated | 2000-4-19 | lld:pubmed |
pubmed-article:10755535 | pubmed:abstractText | Solid organ transplant patients undergoing long-term immunosuppression have high risk of developing lymphomas. The pathogenesis of the late-occurring posttransplantation lymphoproliferative disorders (PTLD) have not yet been extensively investigated. | lld:pubmed |
pubmed-article:10755535 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10755535 | pubmed:language | eng | lld:pubmed |
pubmed-article:10755535 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10755535 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10755535 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10755535 | pubmed:month | Mar | lld:pubmed |
pubmed-article:10755535 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:BarbuiTT | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:RemuzziGG | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:FiocchiRR | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:VieroPP | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:DottiGG | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:GridelliBB | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:RambaldiAA | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:MottaTT | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:GambaAA | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:ManzoniCC | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:GottiEE | lld:pubmed |
pubmed-article:10755535 | pubmed:author | pubmed-author:BorleriGG | lld:pubmed |
pubmed-article:10755535 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10755535 | pubmed:day | 15 | lld:pubmed |
pubmed-article:10755535 | pubmed:volume | 69 | lld:pubmed |
pubmed-article:10755535 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10755535 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10755535 | pubmed:pagination | 827-33 | lld:pubmed |
pubmed-article:10755535 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:meshHeading | pubmed-meshheading:10755535... | lld:pubmed |
pubmed-article:10755535 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10755535 | pubmed:articleTitle | Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. | lld:pubmed |
pubmed-article:10755535 | pubmed:affiliation | Division of Hematology, Ospedali Riuniti di Bergamo, Largo Barozzi, Bergamo, Italy. | lld:pubmed |
pubmed-article:10755535 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10755535 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10755535 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10755535 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10755535 | lld:pubmed |